Theriva Biologics Inc (TOVX)’s stock is trading at $0.86 at the moment marking a fall of -36.76% from the last session close. As of this writing, shares are priced at -93.00% less than their 52-week high of $12.28, and -10.07% over their 52-week low of $0.96. Based on the past 30-day period, the stock price is -44.50% below the high and +4.06% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, TOVX’s SMA-200 is $2.1621.
TOVX’s price to book ratio for the most recent quarter was 0.13, resulting in an 0.21 price to cash per share for the period.
How does Theriva Biologics Inc (TOVX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Theriva Biologics Inc (AMEX: TOVX) Ownership Details
I will give a breakdown of the key shareholders in Theriva Biologics Inc (TOVX). Recent figures show that the company’s insiders hold 0.36% of shares. A total of 12 institutional investors hold shares in the company, making 16.36% of its stock and 16.42% of its float.
Dec 31, 2024 , it was reported that the Company’s largest institutional holder is UBS Group AG holding total of 16.41 shares that make 0.59% of the company’s total number of shares and are currently priced at 13331.0.
The securities firm Citigroup Inc. holds 7.76 shares of TOVX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.28% , and the holding percentage of shares is valued at 6302.0.
An overview of Theriva Biologics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Theriva Biologics Inc (TOVX) traded 2,098,848 shares per day, with a moving average of $1.3187 and price change of -0.2275. With the moving average of $1.2658 and a price change of -0.5875, about 853,819 shares changed hands on average over the past 50 days. Finally, TOVX’s 100-day average volume is 695,081 shares, alongside a moving average of $1.3561 and a price change of -0.4575.
